REVISED: Clarification Regarding Fine Needle Aspiration (FNA) Specimen Adequacy Assessment, Rapid On-site Evaluation (ROSE) and Workload Limits

Published: 11/20/2026

Sources:
  • Clinical Laboratory Improvement Amendments (CLIA),
  • Centers for Medicare and Medicaid Services (CMS)
Relevant To:
  • Critical Access Hospitals,
  • Hospitals

The Centers for Medicare & Medicaid Services (CMS) has provided clarification related to FNA and ROSE under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

A slide assessment that provides only a determination of specimen adequacy is not considered to be a slide examination for purposes of determining workload limits in accordance with 42 CFR 493.1274(d).

Per CMS:

  • During a Fine Needle Aspiration (FNA) procedure, material is aspirated from a suspicious site, and then an adequa…

Sign Up for Free Trial